PHILADELPHIA, April 8, 2021 /PRNewswire/ --
FMC Corporation (NYSE: FMC), a leading agricultural sciences
company, obtained a new mode of action classification for its
proprietary herbicide molecule, tetflupyrolimet. It is the first
active ingredient in the Herbicide Resistance Action Committee
(HRAC) and Weed Science Society of America (WSSA) Group 28 and the
first new herbicide with a novel mode of action in the crop
protection industry in over three decades.
Studies show this new mode of action herbicide provides
season-long control of important grass weeds in the rice market, as
well as key hard-to-control broadleaf weeds and sedges. As
disclosed at its November 2020
Investor Technology Update, FMC plans to start the registration
process and expects to launch products containing tetflupyrolimet
in the transplanted and direct-seeded rice markets in 2023. The use
of tetflupyrolimet is being tested in other crops, including
sugarcane, wheat, soybeans and corn.
"In 2010, our research and development organization in
Delaware made a strategic decision
to focus on discovering new herbicide modes of actions," said
Kathleen Shelton, FMC vice president
and chief technology officer. "The organization believed that
resistance to herbicides would present a significant challenge for
growers in the coming years, and they endeavored to discover a
novel mode of action. To achieve this, the research and development
team screened over 60,000 compounds, synthesized 1,200 analogs and
tested molecules in different crops and weeds around the world. We
are proud of the accomplishments of our scientists who bring their
passion and creativity for innovation to discover new modes of
action, especially in the herbicide area."
Weed resistance is an increasing challenge for growers around
the world, who spend billions of dollars annually trying to control
weeds. "It is hard to overstate the significance of the development
of tetflupyrolimet, which represents an entirely new class of
chemistry and a new mode of action," said Diane Allemang, FMC vice president and chief
marketing officer. "We will be able to provide growers with a
critical new tool to rotate into their weed management program and
achieve control they cannot achieve today. Additionally, due
to its unique mode of action, tetflupyrolimet has no known
cross-resistance."
About FMC
FMC Corporation, an agricultural sciences company, provides
innovative solutions to growers around the world with a robust
product portfolio fueled by a market-driven discovery and
development pipeline in crop protection, plant health, and
professional pest and turf management. This powerful combination of
advanced technologies includes leading insect control products
based on Rynaxypyr® and Cyazypyr® active
ingredients; Authority®, Boral®,
Centium®, Command® and
Gamit® branded herbicides;
Talstar® and Hero® branded
insecticides; and flutriafol-based fungicides. The FMC portfolio
also includes biologicals such as Quartzo® and
Presence® bionematicides. FMC Corporation employs
approximately 6,400 employees around the globe. To learn more,
please visit www.fmc.com.
FMC, the FMC logo, Rynaxypyr, Cyazypyr, Authority, Boral,
Centium, Command, Gamit, Talstar, Hero, Quartzo and Presence are
trademarks of FMC Corporation or an affiliate. Always read and
follow all label directions, restrictions and precautions for use.
Products listed here may not be registered for sale or use in all
states, countries or jurisdictions. Hero® insecticide is
a restricted use pesticide in the United
States.
The Company's investor relations website, located at
https://investors.fmc.com, should be considered as a recognized
channel of distribution, and the Company may periodically post
important information to the website for investors, including
information that the Company may wish to disclose publicly for
purposes of complying with the federal securities laws. After
April 27, 2021, this type of
information will no longer be regularly provided by press release
but will continue to be posted on the investor relations
website.
Statement under the Safe Harbor Provisions of the Private
Securities Litigation Reform Act of 1995: FMC and its
representatives may from time to time make written or oral
statements that are "forward-looking" and provide other than
historical information, including statements contained herein, in
FMC's other filings with the SEC, and in reports or letters to FMC
stockholders.
In some cases, FMC has identified forward-looking statements
by such words or phrases as "will likely result," "is confident
that," "expect," "expects," "should," "could," "may," "will
continue to," "believe," "believes," "anticipates," "predicts,"
"forecasts," "estimates," "projects," "potential," "intends" or
similar expressions identifying "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of
1995, including the negative of those words and phrases. Such
forward-looking statements are based on management's current views
and assumptions regarding future events, future business conditions
and the outlook for the company based on currently available
information. These statements involve known and unknown risks,
uncertainties and other factors that may cause actual results to be
materially different from any results, levels of activity,
performance or achievements expressed or implied by any
forward-looking statement. Currently, one of the most
significant factors is the potential adverse effect of the current
COVID-19 pandemic on the financial condition, results of
operations, cash flows and performance of FMC, which is
substantially influenced by the potential adverse effect of the
pandemic on FMC's customers and suppliers and the global economy
and financial markets. The extent to which COVID-19 impacts us will
depend on future developments, which are highly uncertain and
cannot be predicted with confidence, including the scope, severity
and duration of the pandemic, the actions taken to contain the
pandemic or mitigate its impact, and the direct and indirect
economic effects of the pandemic and containment measures, among
others. Additional factors include, among other things, the
risk factors and other cautionary statements included within FMC's
2020 Form 10-K filed with the SEC as well as other SEC filings and
public communications. Moreover, investors are cautioned to
interpret many of these factors as being heightened as a result of
the ongoing and numerous adverse impacts of the COVID-19
pandemic.
FMC cautions readers not to place undue reliance on any such
forward-looking statements, which speak only as of the date made.
Forward-looking statements are qualified in their entirety by the
above cautionary statement. FMC undertakes no obligation, and
specifically disclaims any duty, to update or revise any
forward-looking statements to reflect events or circumstances
arising after the date on which they were made, except as otherwise
required by law.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/novel-herbicide-tetflupyrolimet-from-fmc-corporation-granted-a-new-mode-of-action-classification-301265257.html
SOURCE FMC Corporation